Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science - Editorial comments
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Heterogeneity and complexity of native brain nicotinic receptors
Role of endogenous nicotinic signaling in guiding neuronal development
Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors
Age-dependent changes in the functional expression of two nicotinic receptor subtypes in CA1 stratum radiatum interneurons in the rat hippocampus
Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation
Allosteric modulation of nicotinic acetylcholine receptors
Structure-guided drug design: Conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes ☆
In vitro screening strategies for nicotinic receptor ligands
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function
Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men
Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Focus on cognition
Nicotinic receptors as CNS targets for Parkinson's disease
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Behavioral modulation of neuronal calcium/calmodulin-dependent protein kinase II activity: Differential effects on nicotine-induced spinal and supraspinal antinociception in mice ☆
A-366833: A novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane α4β2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models
Multiple brain pathways and receptors underlying tobacco addiction
Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD)
Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo
Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats
The role of the nicotinic acetylcholine receptors in sleep-related epilepsy
Overexpression of SLURP-1 and -2 alleviates the tumorigenic action of tobacco-derived nitrosamine on immortalized oral epithelial cells